Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cognition Therapeutics, Inc. - Common Stock
(NQ:
CGTX
)
1.120
+0.050 (+4.67%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cognition Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Monday's after hours session: top gainers and losers
↗
July 07, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 07, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
July 07, 2025
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 07, 2025
Via
Benzinga
Which stocks are moving after the closing bell on Friday?
↗
July 04, 2025
The US market regular session of Friday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
Cognition Therapeutics Shares Jump 12% After Hours Following Encouraging Phase 2 Alzheimer's Trial Data
↗
July 04, 2025
Cognition Therapeutics Inc (NASDAQ: CGTX) continued to gain 12.10% in after-hours trading on Thursday, after a 20.82% surge during regular market hours.
Via
Benzinga
Sonnet BioTherapeutics Drops 5% Intraday, Rebounds 14% After Hours Amid Delisting Concerns
↗
July 03, 2025
Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) fell 5.54% on Thursday to close at $3.92, before rebounding 14.29% in after-hours trading to $4.48, amid concerns of a potential NASDAQ delisting.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 03, 2025
Via
Benzinga
Top movers in Thursday's after hours session
↗
July 03, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
July 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 17, 2025
Via
Benzinga
These stocks are moving in today's pre-market session
↗
June 05, 2025
Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
June 05, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
May 08, 2025
Via
Benzinga
Earnings Scheduled For March 20, 2025
↗
March 20, 2025
Via
Benzinga
Cognition Therapeutics Presents Phase 2 Results For Drug To Fight DLB At International Conference
February 06, 2025
Cognition Therapeutics Presents Phase 2 Results For Drug To Fight DLB At International Conference
Via
News Direct
Cognition Therapeutics Is Targeting A Critical Form Of Dementia
January 13, 2025
Cognition Therapeutics Is Targeting A Critical Form Of Dementia
Via
News Direct
Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial
December 20, 2024
Topline Results Are In: Cognition Therapeutics’ Drug To Fight Dementia With Lewy Bodies Shows Encouraging Results In Phase 2 Trial
Via
News Direct
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 18, 2024
Via
Benzinga
Why Is Penny Stock Cognition Therapeutics Trading Over 93% On Wednesday?
↗
December 18, 2024
Cognition Therapeutics' CT1812 improves dementia with Lewy bodies outcomes, reducing anxiety, hallucinations, and functional decline in trials.
Via
Benzinga
November’s Small-Cap Treasures: 3 Stocks Poised for Growth
November 04, 2024
Three promising small-cap stocks, poised for growth in healthcare, cybersecurity, and renewable energy, offer compelling investment opportunities for November.
Via
MarketBeat
Topics
Economy
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 30, 2024
Via
Benzinga
CGTX Stock Earnings: Cognition Therapeutics Beats EPS for Q2 2024
↗
August 08, 2024
CGTX stock results show that Cognition Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
July 30, 2024
Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!
Via
InvestorPlace
Dow Edges Lower; Ventyx Biosciences Shares Plummet
↗
July 29, 2024
Via
Benzinga
Topics
Stocks
Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
July 29, 2024
Via
Benzinga
Crude Oil Moves Lower; NLS Pharmaceutics Shares Jump
↗
July 29, 2024
Via
Benzinga
Tivic Health Systems (TIVC) Stock Pops Another 39%
↗
July 29, 2024
Tivic Health Systems stock is up on Monday with heavy trading of TIVC shares as recent volatility continues for the company's units.
Via
InvestorPlace
Cognition Therapeutics Stock Tumbles On Mixed Data From Mid-Stage Alzheimer's Study
↗
July 29, 2024
Cognition Therapeutics' Phase 2 'SHINE' study shows CT1812 leads to cognitive improvement in Alzheimer's patients over six months. Participants showed better performance on cognitive and functional...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.